glp-1 requirements for insurance coverage 🚨 Important Update SHBP Members 🚨 State Health Benefit Plan has new prescribing rules starting February 1, 2026. ✔️ You may continue filling GLP-1 medications for weight loss with your Some insurers are dropping GLP-1

Clinical Diabetology

For instance, the subcutaneously injected drug Semaglutide 2.4 mg, approved in 2021 and administered once a week, has been shown to achieve an average weight reduction of 15%-17% and also offers cardiovascular protective effects

[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Grunvald E., Shah R., Hernaez R., Chandar A.K., Pickett-Blakely O., Teigen L.M., Harindhanavudhi T., Sultan S., Singh S., Davitkov P., et al

The analysis, titled Are All Incretin Therapies Equal for the Kidney

10.1056/NEJMoa1509225 [DOI] [PubMed] [Google Scholar] 33

Both nausea and vomiting are usually transient and of mild-to-moderate severity, with the frequency more pronounced at the beginning of treatment and people developing a tolerance over time [99]